Healthcare Biocon: The Pegfilgrastim opportunity Updated : May 28, 2018 10:30 AM IST Biosimilars are better propostions for companies. The USFDA has approved Biocon's first biosimilar applications in the US in 2017, Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.